Antidepressants in clinical practice: Limitations of assessment methods and drug response

被引:35
|
作者
Kennedy, SH [1 ]
Eisfeld, BS [1 ]
Meyer, JH [1 ]
Bagby, RM [1 ]
机构
[1] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5T 1RB, Canada
关键词
antidepressants; efficacy; diagnostic heterogeneity functional brain imaging; Major Depressive Disorder;
D O I
10.1002/hup.189
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is a recognized gap between knowledge derived from 'efficacy' data - based on usually brief randomized controlled trials and findings in natural practice 'effectiveness' studies. In considering the limitations of current antidepressants in clinical practice, we have selected three clinically important issues to examine in a natural practice data base that has been in existence for several years. These relate to: (I) Diagnostic heterogeneity and potential advances using functional brain imaging; (2) Variability of outcome measures during treatment and (3) Time to response and prediction of outcome. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:105 / 114
页数:10
相关论文
共 50 条
  • [21] ASSESSMENT OF RELAXATION IN CLINICAL PRACTICE - METHODS FOR ROUTINE AND RESEARCH
    STOVNER, J
    HOLSTLARSEN, H
    HARBO, S
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1978, : 103 - 105
  • [22] A systematic assessment of deep learning methods for drug response prediction: from in vitro to clinical applications
    Shen, Bihan
    Feng, Fangyoumin
    Li, Kunshi
    Lin, Ping
    Ma, Liangxiao
    Li, Hong
    BRIEFINGS IN BIOINFORMATICS, 2023, 24 (01)
  • [23] THE CLINICAL AND THERAPEUTIC ASSESSMENT OF ATYPICAL ANTIDEPRESSANTS
    PANTELEEVA, GP
    BELYAEV, BS
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1989, 89 (10): : 115 - 119
  • [24] Assessment of Function Limitations in People with Chronic Kidney Disease for Implementation in Clinical Practice
    Koufaki, Pelagia
    KIDNEY AND DIALYSIS, 2022, 2 (02): : 234 - 244
  • [25] The use of antidepressants in clinical practice: focus on agomelatine
    McAllister-Williams, R. H.
    Baldwin, D. S.
    Haddad, P. M.
    Bazire, S.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (02) : 95 - 102
  • [26] Antidepressants:: general practitioners' opinions and clinical practice
    Rambelomanana, S
    Depont, F
    Forest, K
    Hébert, G
    Blazejewski, S
    Fourrier-Réglat, A
    Molimard, M
    Moore, N
    ACTA PSYCHIATRICA SCANDINAVICA, 2006, 113 (06) : 460 - 467
  • [27] PLASMA LEVELS OF ANTIDEPRESSANTS AND CLINICAL RESPONSE
    GRUVSTAD, M
    LANCET, 1973, 1 (7794): : 95 - 96
  • [28] COURSE OF CLINICAL-RESPONSE TO ANTIDEPRESSANTS
    LAPIERRE, YD
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1985, 9 (5-6): : 503 - 507
  • [29] Therapeutic drug monitoring of antidepressants - clinical aspects
    Laux, G.
    Baumann, P.
    Hiemke, C.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2007, (72): : 261 - 267
  • [30] Assessment of drug-induced liver injury in clinical practice
    Lucena, M. Isabel
    Garcia-Cortes, Miren
    Cueto, Raquel
    Lopez-Duran, J. L.
    Andrade, Raul J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 (02) : 141 - 158